Susanna Ranta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susanna Ranta has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Aune Hirvasniemi
3 shared publicationsAlbert de la Chapelle
Folkhälsan Institute of Genetics, Helsinki, Finland
2 shared publicationsAnna-Elina Lehesjoki
Folkhälsan Institute of Genetics, Helsinki, Finland
2 shared publicationsBarbara Ross
Columbia Genome Center, Columbia University, New York, USA
2 shared publicationsElina Takkunen
Folkhälsan Institute of Genetics, Helsinki, Finland
2 shared publicationsYonghui Zhang
Columbia Genome Center, Columbia University, New York, USA
2 shared publications
Latest Publications
- 1 May 2000
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 8 (5) , 381-384
Positional cloning and characterisation of the human DLGAP2 gene and its exclusion in progressive epilepsy with mental retardation
In search of the gene for progressive epilepsy with mental retardation (EPMR) we identified DLGAP2, the human homolog of the gene encoding the rat PSD-95/SAP90-associated protein-2 (Dlgap2). We extended the transcript in both the 5′ and 3′ directions and characterised the genomic structure of the approximately 10 kb gene. Sequence comparisons of human DLGAP2 cDNA sequences obtained from human testis and brain cDNA libraries with homologous rat genes suggest alternative splicing in the 5′ end of the gene. The 5′ coding sequence of the testis cDNA is complete, whereas based on homology with the rat gene 103 bp of coding sequence may still be missing in the 5′ end of the DLGAP2 brain transcript. DLGAP2 was excluded as the gene responsible for EPMR
- 1 May 2000
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 8 (5) , 381-384
Positional cloning and characterisation of the human DLGAP2 gene and its exclusion in progressive epilepsy with mental retardation
In search of the gene for progressive epilepsy with mental retardation (EPMR) we identified DLGAP2, the human homolog of the gene encoding the rat PSD-95/SAP90-associated protein-2 (Dlgap2). We extended the transcript in both the 5′ and 3′ directions and characterised the genomic structure of the approximately 10 kb gene. Sequence comparisons of human DLGAP2 cDNA sequences obtained from human testis and brain cDNA libraries with homologous rat genes suggest alternative splicing in the 5′ end of the gene. The 5′ coding sequence of the testis cDNA is complete, whereas based on homology with the rat gene 103 bp of coding sequence may still be missing in the 5′ end of the DLGAP2 brain transcript. DLGAP2 was excluded as the gene responsible for EPMR
- 1 October 1999
- Published by Springer Nature in Nature Genetics
- Vol. 23 (2) , 233-236
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8
The neuronal ceroid lipofuscinoses (NCLs) are a genetically heterogeneous group of progressive neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigment in various tissues1. Progressive epilepsy with mental retardation (EPMR, MIM 600143) was recently recognized as a new NCL subtype2 (CLN8). It is an autosomal recessive disorder characterized by onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation3. Here we report the positional cloning of a novel gene, CLN8, which is mutated in EPMR. It encodes a putative transmembrane protein. EPMR patients were homozygous for a missense mutation (70C→G, R24G) that was not found in homozygosity in 433 controls. We also cloned the mouse Cln8 sequence. It displays 82% nucleotide identity with CLN8, conservation of the codon harbouring the human mutation and is localized to the same region as the motor neuron degeneration mouse, mnd, a naturally occurring mouse NCL (ref. 4). In mnd/mnd mice, we identified a homozygous 1-bp insertion (267-268insC, codon 90) predicting a frameshift and a truncated protein. Our data demonstrate that mutations in these orthologous genes underlie NCL phenotypes in human and mouse, and represent the first description of the molecular basis of a naturally occurring animal model for NCL.
- 1 October 1999
- Published by Springer Nature in Nature Genetics
- Vol. 23 (2) , 233-236
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8
The neuronal ceroid lipofuscinoses (NCLs) are a genetically heterogeneous group of progressive neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigment in various tissues1. Progressive epilepsy with mental retardation (EPMR, MIM 600143) was recently recognized as a new NCL subtype2 (CLN8). It is an autosomal recessive disorder characterized by onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation3. Here we report the positional cloning of a novel gene, CLN8, which is mutated in EPMR. It encodes a putative transmembrane protein. EPMR patients were homozygous for a missense mutation (70C→G, R24G) that was not found in homozygosity in 433 controls. We also cloned the mouse Cln8 sequence. It displays 82% nucleotide identity with CLN8, conservation of the codon harbouring the human mutation and is localized to the same region as the motor neuron degeneration mouse, mnd, a naturally occurring mouse NCL (ref. 4). In mnd/mnd mice, we identified a homozygous 1-bp insertion (267-268insC, codon 90) predicting a frameshift and a truncated protein. Our data demonstrate that mutations in these orthologous genes underlie NCL phenotypes in human and mouse, and represent the first description of the molecular basis of a naturally occurring animal model for NCL.